A rise in the use of non-FDA-approved diabetes and obesity medications has spurred health care professionals and medical ...

We've all seen the various inspection labels at the grocery store and heard news about food recalls. But what's the actual ...

The FDA’s Oncologic Drugs Advisory Committee recently voted to narrow the label for checkpoint inhibitors Keytruda and Opdivo ...

is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application for FP008, its first-in-class immunocytokine designed to address ...

Legally, when a drug approved by the Food and Drug Administration (FDA) is in shortage ... "There’s likely to be some sticker shock for many, and whether they’ll be able to continue to afford the ...

The FDA is reviewing the application for bentracimab for use as a ticagrelor reversal agent in patients with uncontrolled bleeding or in those who require urgent surgery or invasive procedure.

It noted at the time more countries would get access as regulators approved the feature, and the FDA was apparently the first to come through outside of Europe, boosting support to 15 countries.

In response to the FDA declaring on Friday that the shortage for Novo’s blockbuster GLP-1 treatments Ozempic, approved for diabetes ... added that there will be “sticker shock for many ...

Feb. 25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use disorder (OUD) to start and keep up with ...

The OFA additionally argued that even producers of FDA-approved semaglutide revealed in a recent SEC filing that the “supply constraints’ and ‘drug shortage notifications’ will continue into the ...

The US Food and Drug Administration’s new standards for foods before they can be labeled as “healthy” on their packaging will go into effect about two months later than planned, according to a ...

Compounders are on alert after the US Food and Drug Administration (FDA) declared the shortage of semaglutide –the active ingredient in glucagon-like peptide 1 receptor agonist (GLP-1RA) Wegovy ...